We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Prometheus Launches Test to Predict Risk of Complications From Crohn’s
Prometheus Launches Test to Predict Risk of Complications From Crohn’s
August 31, 2010
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, Tuesday announced the commercial launch of its proprietary PROMETHEUS Crohn’s Prognostic test. TheStreet
